These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4735101)

  • 21. Morphine abstinence syndrome: cholinergic mechanisms in the ventral periaqueductal gray of the dog.
    Sharpe LG; Pickworth WB
    NIDA Res Monogr; 1984 Mar; 49():143-9. PubMed ID: 6434952
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of GABA-positive agents on the formation of morphine dependence and on the manifestations of a withdrawal syndrome].
    Belozertseva IV; Andreev BV
    Eksp Klin Farmakol; 2000; 63(1):19-23. PubMed ID: 10763104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.
    Kosten TA; DeCaprio JL; Rosen MI
    Neuropsychopharmacology; 1995 Dec; 13(4):323-33. PubMed ID: 8747757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine.
    Mundey MK; Mason R; Wilson VG
    Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of spontaneous and precipitated nicotine withdrawal in the mouse.
    Damaj MI; Kao W; Martin BR
    J Pharmacol Exp Ther; 2003 Nov; 307(2):526-34. PubMed ID: 12970387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of withdrawal symptoms in morphine addicted albino rats.
    Raman G; Ahmed M
    Indian J Exp Biol; 1977 Mar; 15(3):238-9. PubMed ID: 199541
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppression of the drug-induced morphine withdrawal syndrome by cyproheptadine.
    Opitz K; Reimann I
    Psychopharmacologia; 1973 Jan; 28(2):165-70. PubMed ID: 4735135
    [No Abstract]   [Full Text] [Related]  

  • 28. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
    Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR
    Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine.
    Feily A; Abbasi N
    Phytother Res; 2009 Nov; 23(11):1549-52. PubMed ID: 19370548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antidepressant withdrawal symptoms treated with anticholinergic agents.
    Dilsaver SC; Feinberg M; Greden JF
    Am J Psychiatry; 1983 Feb; 140(2):249-51. PubMed ID: 6849449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute administration of pioglitazone attenuates morphine withdrawal syndrome in rat: a novel role of pioglitazone.
    Ghavimi H; Azarfardian A; Maleki-Dizaji N; Hassanzadeh K; Ghanbarzadeh S; Charkhpour M
    Drug Res (Stuttg); 2015 Mar; 65(3):113-8. PubMed ID: 24504689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evaluation of mecamylamine for withdrawal from nicotine dependence.
    Tennant FS; Tarver AL; Rawson RA
    NIDA Res Monogr; 1984 Mar; 49():239-46. PubMed ID: 6434966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug dependence: a pharmacological analysis.
    Collier HO
    Br J Addict Alcohol Other Drugs; 1972 Dec; 67(4):277-86. PubMed ID: 4265240
    [No Abstract]   [Full Text] [Related]  

  • 35. Attenuation of morphine withdrawal signs by muscimol in the locus coeruleus of rats.
    Mirzaii-Dizgah I; Karimian SM; Hajimashhadi Z; Riahi E; Ghasemi T
    Behav Pharmacol; 2008 May; 19(3):171-5. PubMed ID: 18469534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent.
    Zhu H; Barr GA
    Synapse; 2001 Jun; 40(4):282-93. PubMed ID: 11309844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neurotropin suppression of the manifestations of the naloxone-provoked withdrawal syndrome in morphine-dependent rats].
    Sudakov SK; Konstantinopol'skiĭ MA; Surkova LA; Tiurina IV; Konishi J; Yumia H
    Farmakol Toksikol; 1991; 54(4):16-8. PubMed ID: 1786813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
    Kang L; Wang D; Li B; Hu M; Zhang P; Li J
    Am J Drug Alcohol Abuse; 2008; 34(5):541-52. PubMed ID: 18618337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice.
    Pałucha-Poniewiera A; Novák K; Pilc A
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1454-7. PubMed ID: 19660510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of agmatine on tolerance to and substance dependence on morphine in mice.
    Li J; Li X; Pei G; Qin BY
    Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):232-8. PubMed ID: 10452098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.